7 Reasons to Be Wary of Financial Advice from Almost Anyone
High Rates Make SolarCity Bonds Shine, but Beware the Clouds
Toxic Chemicals Taint Many Halloween Costumes, Products
Is There Life After Kim Kardashian for Glu Mobile?
View this photo on glassdoor.com
Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More?
The $300,000 Drug
Vertex Pharmaceuticals Incorporated's $300,000 A Year Drug Is Denied, And Medicaid Patients Sue
GNW-News: BB BIOTECH AG: Biotech sector recovers from market correction - new products and M&A the main drivers (english)
Hepatitis C: Game changing regimens to revolutionise treatment landscape - KOL Insight
OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 - Event-Driven Update
Oxford Global's inaugural Drug Discovery USA Congress, 21st & 22nd October 2014, Boston
Fed: Beware of social media, biotech stocks
Global Nanobiotechnology Report - Forecasts to 2023
INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated